回到 StockQ 正常版首頁 |
柏瑞新興市場企業策略債券基金-N類型/月配息
| ||||||||||||
年度報酬率 |
2019 | 2020 | 2021 | 2022 | 2023 | |
淨值 | 5.29% | 0.26% | -9.89% | -18.41% | -4.59% |
含息 | 5.29% | 1.37% | -2.74% | -11.36% | 2.44% |
近期配息記錄 |
2022年 | 配息 | 前日淨值 | 殖利率 |
01/03 | 0.0596 | 9.0126 | 0.66% |
02/07 | 0.0596 | 8.7530 | 0.68% |
03/01 | 0.0596 | 8.4316 | 0.71% |
04/01 | 0.0596 | 8.1687 | 0.73% |
05/03 | 0.0596 | 7.9628 | 0.75% |
06/01 | 0.0596 | 7.8546 | 0.76% |
07/01 | 0.0494 | 7.5289 | 0.66% |
08/01 | 0.0494 | 7.5607 | 0.65% |
09/01 | 0.0494 | 7.5142 | 0.66% |
10/03 | 0.0431 | 7.1250 | 0.60% |
11/01 | 0.0431 | 6.9985 | 0.62% |
12/01 | 0.0431 | 7.2676 | 0.59% |
2022總計 | 0.6351 | 7.2676 | 8.74% |
2023年 | 配息 | 前日淨值 | 殖利率 |
01/03 | 0.0431 | 7.3537 | 0.59% |
02/01 | 0.0431 | 7.4531 | 0.58% |
03/01 | 0.0431 | 7.2925 | 0.59% |
04/06 | 0.0431 | 7.2332 | 0.60% |
05/02 | 0.0431 | 7.2410 | 0.60% |
06/01 | 0.0431 | 7.1672 | 0.60% |
07/03 | 0.0431 | 7.1972 | 0.60% |
08/01 | 0.0431 | 7.1606 | 0.60% |
09/01 | 0.0431 | 7.0385 | 0.61% |
10/02 | 0.0431 | 6.9080 | 0.62% |
11/01 | 0.0431 | 6.7735 | 0.64% |
12/01 | 0.0431 | 6.9122 | 0.62% |
2023總計 | 0.5172 | 6.9122 | 7.48% |
2024年 | 配息 | 前日淨值 | 殖利率 |
01/02 | 0.0361 | 7.0160 | 0.51% |
02/01 | 0.0361 | 7.0360 | 0.51% |
03/01 | 0.0361 | 7.0165 | 0.51% |
04/01 | 0.0361 | 7.0464 | 0.51% |
05/02 | 0.0361 | 6.8792 | 0.52% |
06/03 | 0.0361 | 6.9389 | 0.52% |
07/01 | 0.0361 | 6.9650 | 0.52% |
08/01 | 0.0361 | 7.0006 | 0.52% |
09/02 | 0.0361 | 7.0556 | 0.51% |
10/01 | 0.0361 | 7.0535 | 0.51% |
11/01 | 0.0361 | 6.9608 | 0.52% |
2024總計 | 0.3971 | 6.9608 | 5.70% |
柏瑞新興市場企業策略債券基金-N類型/月配息 |
日期 | 淨值 | 漲跌比例 |
2024/11/19 | 6.9057 | 0.06% |
2024/11/18 | 6.9013 | -0.09% |
2024/11/15 | 6.9074 | -0.15% |
2024/11/14 | 6.9178 | 0.02% |
2024/11/13 | 6.9164 | -0.05% |
2024/11/12 | 6.9202 | -0.21% |
2024/11/11 | 6.9351 | 0.06% |
2024/11/08 | 6.9310 | 0.21% |
2024/11/07 | 6.9167 | 0.31% |
2024/11/06 | 6.8951 | -0.19% |
名稱 | 三個月 | 六個月 | 一年 | 今年 |
柏瑞新興市場企業策略債券基金-N類型/月配息/人民幣 | -1.87% | -0.47% | 0.78% | -1.57% |
| ||||||||||||
StockQ 全球股市指數 © All rights reserved.
|